Corline Biomedical

Corline Biomedical CROIC

The Cash Return on Invested Capital (CROIC) of Corline Biomedical (CLBIO.ST) as of Oct 23, 2026 is -18.92 %. In the previous year, Cash Return on Invested Capital (CROIC) was -18.57 % — a change of 1.89% (lower).

CROIC

-18.92 %

YoY

1.89%

Last updated:

Cash Return on Invested Capital (CROIC) of Corline Biomedical is 2025 -18.92 % . Cash Return on Invested Capital (CROIC) of Corline Biomedical was 2024 -18.57 % . It decreases by 1.89% lower compared to the previous year.

The Corline Biomedical CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
-9.17 SEK
Jan 1, 2019
-31.50 SEK
Jan 1, 2020
-26.65 SEK
Jan 1, 2021
-15.67 SEK
Jan 1, 2022
-16.33 SEK
Jan 1, 2023
-10.43 SEK
Jan 1, 2024
-18.57 SEK
Jan 1, 2025
-18.92 SEK
The Corline Biomedical CROIC history
YEARCROICYoY
-18.92 %+1.89%
-18.57 %+77.96%
-10.43 %-36.13%
-16.33 %+4.25%
-15.67 %-41.20%
-26.65 %-15.39%
-31.50 %+243.40%
-9.17 %-57.87%
-21.77 %-46.43%
-40.64 %-4.84%
-42.71 %+25.46%
-34.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Corline Biomedical Stock analysis

What does Corline Biomedical do? Corline Biomedical AB, headquartered in Uppsala, Sweden, operates in the Health Care sector, specifically within Pharmaceuticals. The company focuses on the research, development, and commercialization of heparin-based solutions for kidney transplantation, cell therapies, and regenerative medicine applications. Listed on 3 June 2015, Corline Biomedical employs eight people and is dedicated to advancing medical treatments through innovative heparin-based technologies. Corline Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corline Biomedical stock

Cash Return on Invested Capital (CROIC) of Corline Biomedical is -18.92 % in 2025.

Cash Return on Invested Capital (CROIC) of Corline Biomedical changed from -18.57 % to -18.92 %, representing a 1.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Corline Biomedical since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Corline Biomedical with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Corline Biomedical

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Corline Biomedical